Daniel Suez, MD
Allergy & Immunology · Irving, TXNPI 1255312773
Payments from drug & device makers
Across 624 payments — averaging $636.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Grifols Therapeutics LLC$146K
- Takeda Pharmaceuticals U.S.A., Inc.$105K
- ADMA Biomanufacturing LLC$36K
- Biocryst Pharmaceuticals, Inc.$14K
- Shire North American Group Inc$13K
- CSL Behring$13K
- plus $71K from 37 others
Across 18 payments — averaging $978.33 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- ADMA Biomanufacturing LLC$8K
- Takeda Pharmaceuticals U.S.A., Inc.$5K
- Consortium Of Independent Immunology Clinics, LLC$4K
What the payments were for
- Consulting fees$12,92816%
- Speaking & faculty fees$43,55856%
- Travel & lodging$2,4153%
- Food & beverage$14,91919%
- Education$1530%
- Gifts$4,1905%
- Other$2340%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$397,344 in reported general payments places this provider in the 95th percentile of 336 allergy & immunology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Azithromycin | 25 | $107 |
| Montelukast Sodium | 17 | $68 |
Paid to pharmacies, not to this prescriber.
Other allergy & immunology in Irving
- William HowlandAustin$3.6M
- Russell PerryBeaumont$3.2M
- Barbara BaxterDallas$2.5M
- Lyndon MansfieldEl Paso$2.4M
- Dale MoharKerrville$2.3M
- Erika GonzalezSan Antonio$2.2M
- Richard WassermanDallas$1.9M
- Joseph DiazSan Antonio$1.8M
- Niran AmarWaco$840K
- Robert JacobsSan Antonio$757K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.